Tower Research Capital (TRC)’s Aimei Health Technology AFJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-48
Closed -$514 – 5138
2024
Q4
$514 Buy
48
+34
+243% +$360 ﹤0.01% 5249
2024
Q3
$147 Buy
+14
New +$146 ﹤0.01% 5465

Other funds holding AFJK

Tower Research Capital (TRC)'s AFJK Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Aimei Health Technology (AFJK) in Q1 2025, closing a stake of 48 shares — an estimated $514 sold.

Tower Research Capital (TRC) first reported a position in AFJK in Q3 2024 and held it in 2 quarters. The position peaked at $514 in Q4 2024. 16 funds tracked by Wall St. Rank hold AFJK as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Aimei Health Technology position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 48 Aimei Health Technology shares in Q1 2025, an estimated $514.
  • Tower Research Capital (TRC) first reported a position in Aimei Health Technology in Q3 2024 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Aimei Health Technology position peaked at $514 in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Aimei Health Technology as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.